In order to thrive, you need to have all of the tools at your fingertips, and that includes evidence-based therapies that go beyond conventional oncology.
To learn more about evidence-based therapies for Pancreatic Cancer, click the orange button to the right.
adjuvant modified FOLFIRINOX therapy in the PRODIGE 24 trial have now changed the standard of care for many patients with resectable tumors… To say that Folfirinox (FOL) for early pancreatic cancerContinue reading
Treatment based on genomic profiling, also known as precision medicine, may hold the promise of improved outcomes for a subset of patients with pancreatic cancer. Genomic profiling for pancreatic cancerContinue reading
Low-dose Naltrexone (LDN) – Inexpensive, Evidence-based Pancreatic Cancer Therapy As a long term survivor of an incurable cancer, Multiple Myeloma, it became clear to me many years ago that manyContinue reading
An overview of the evidence-based, non-conventional therapies that have been evaluated (but not FDA-approved) for Pancreatic Cancer treatment.Continue reading